GENEREX BIOTECHNOLOGY CORP — Net Income by Fiscal Year
24 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/05266242-b542-4ef5-bc49-dd7cb7de074c/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2020 | $-34.2M | 2019-08-01 – 2020-07-31 | evidence 0001607062-20-000327 |
| FY 2019 | $-11.0M | 2018-08-01 – 2019-07-31 | evidence 0001607062-19-000429 |
| FY 2018 | $35.9M | 2017-08-01 – 2018-07-31 | evidence 0001607062-18-000361 |
| FY 2017 | $-76.8M | 2016-08-01 – 2017-07-31 | evidence 0001607062-17-000349 |
| FY 2016 | $-3.2M | 2015-08-01 – 2016-07-31 | evidence 0001607062-17-000021 |
| FY 2015 | $-2.2M | 2014-08-01 – 2015-07-31 | evidence 0001607062-15-000445 |
| FY 2014 | $-1.4k | 2013-08-01 – 2014-07-31 | evidence 0001607062-14-000128 |
| FY 2013 | $-365.1M | 1996-02-02 – 2014-04-30 | evidence 0001607062-14-000015 |
| FY 2012 | $-359.2M | 1995-11-02 – 2013-04-30 | evidence 0001144204-13-034142 |
| FY 2011 | $-352.6M | 1995-11-02 – 2012-04-30 | evidence 0001144204-12-034225 |
| FY 2010 | $-25.3M | 2009-08-01 – 2010-07-31 | evidence 0001554795-13-000602 |
| FY 2009 | $-45.8M | 2008-07-31 – 2009-07-31 | evidence 0001144204-12-056138 |
| FY 2008 | $-36.2M | 2007-08-01 – 2008-07-31 | evidence 0001144204-12-056138 |
| FY 2007 | $-23.5M | 2006-08-01 – 2007-07-31 | evidence 0001554795-13-000602 |
| FY 2006 | $-68.0M | 2005-07-31 – 2006-07-31 | evidence 0001144204-12-056138 |
| FY 2005 | $-24.0M | 2004-08-01 – 2005-07-31 | evidence 0001554795-13-000602 |
| FY 2004 | $-18.4M | 2003-08-01 – 2004-07-31 | evidence 0001144204-12-056138 |
| FY 2003 | $-13.3M | 2002-08-01 – 2003-07-31 | evidence 0001554795-13-000602 |
| FY 2002 | $-13.7M | 2001-08-01 – 2002-07-31 | evidence 0001554795-13-000602 |
| FY 2001 | $-27.1M | 2000-08-01 – 2001-07-31 | evidence 0001554795-13-000602 |
| FY 2000 | $-8.8M | 1999-08-01 – 2000-07-31 | evidence 0001144204-12-056138 |
| FY 1999 | $-6.2M | 1998-08-01 – 1999-07-31 | evidence 0001554795-13-000602 |
| FY 1998 | $-4.7M | 1997-08-01 – 1998-07-31 | evidence 0001554795-13-000602 |
| FY 1997 | $-1.4M | 1996-08-01 – 1997-07-31 | evidence 0001554795-13-000602 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
GENEREX BIOTECHNOLOGY CORP — all facts · Revenue · Operating Income